{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:14:56Z","timestamp":1761059696109},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/jjco\/hyu018","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T02:05:43Z","timestamp":1396317943000},"page":"479-485","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Everolimus in Patients with Advanced Renal Cell Carcinoma Refractory or Intolerant to VEGFR-TKIs and Safety Compared with Prior VEGFR-TKI Treatment"],"prefix":"10.1093","volume":"44","author":[{"given":"Renpei","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,30]]},"reference":[{"key":"key\n\t\t\t\t20170511082030_HYU018C1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"key\n\t\t\t\t20170511082030_HYU018C2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20170511082030_HYU018C3","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1074\/jbc.M310872200","article-title":"Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth","volume":"279","author":"Lynch","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511082030_HYU018C4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2008.10.016","article-title":"HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma","volume":"14","author":"Gordan","year":"2008","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170511082030_HYU018C5","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/cncr.25219","article-title":"Phase 3 trial of everolimus for metastatic renal cell carcinoma","volume":"116","author":"Motzer","year":"2010","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170511082030_HYU018C6","article-title":"European Association of Urology (EAU) online guideline on renal cell carcinoma","year":"2010"},{"key":"key\n\t\t\t\t20170511082030_HYU018C7","article-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines) kidney cancer, version 2","year":"2011"},{"key":"key\n\t\t\t\t20170511082030_HYU018C8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jjco\/hyq166","article-title":"Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1","volume":"41","author":"Tsukamoto","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t20170511082030_HYU018C9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2004.06.132","article-title":"Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma","volume":"22","author":"Motzer","year":"2004","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170511082030_HYU018C10","doi-asserted-by":"crossref","first-page":"34495","DOI":"10.1074\/jbc.C800170200","article-title":"Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2","volume":"283","author":"Toschi","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511082030_HYU018C11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-09-3965","article-title":"Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511082030_HYU018C12","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1002\/cncr.25583","article-title":"Sunitinib rechallenge in metastatic renal cell carcinoma patients","volume":"116","author":"Zama","year":"2010","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170511082030_HYU018C13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1158\/0008-5472.CAN-11-2739","article-title":"Targeting protein synthesis in a Myc\/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival","volume":"72","author":"Robert","year":"2012","journal-title":"Cancer Res"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20170511082030_HYU018C14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1053\/j.seminoncol.2009.10.013","article-title":"Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma","volume":"36","author":"Hudes","year":"2009","journal-title":"Semin Oncol"},{"key":"key\n\t\t\t\t20170511082030_HYU018C15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"key\n\t\t\t\t20170511082030_HYU018C16","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1091\/mbc.01-12-0584","article-title":"Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake","volume":"13","author":"Edinger","year":"2002","journal-title":"Mol Biol Cell"},{"key":"key\n\t\t\t\t20170511082030_HYU018C17","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/diabetes.53.11.2748","article-title":"Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170511082030_HYU018C18","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1158\/1535-7163.MCT-10-0873","article-title":"Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers","volume":"9","author":"Pal","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170511082030_HYU018C19","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","article-title":"The role of the mammalian target of rapamycin (mTOR) in renal disease","volume":"20","author":"Lieberthal","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/44\/5\/479\/11686567\/hyu018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T14:48:55Z","timestamp":1503499735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article-lookup\/doi\/10.1093\/jjco\/hyu018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,30]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,3,30]]},"published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyu018","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,30]]}}}